COVID-19 has challenged governments and the public health community to consider how to manage the synergistic effects of pandemic infection, endemic infectious disease, and the noncommunicable diseases (NCDs) that are now among the leading causes of death around the world.
The connection between tuberculosis (TB) and diabetes has been known for many years – people with TB are more likely to develop diabetes and diabetes triples the risk of developing TB, compared to people without those co-morbidities. But now COVID-19 has further exacerbated these linkages. People living with NCDs like diabetes are more likely to develop severe cases and die from COVID-19, and there is evidence that patients with TB are at increased risk for COVID-19, putting millions at risk.
Integrating preventive and treatment interventions to address diabetes within TB care is essential to addressing these dangerous co-morbidities and achieving more equitable care for all. However, health systems in low- and middle- income countries often face challenges in integrating NCD and infectious disease care due to the siloed nature of health funding and education.
Join us to hear a diverse group of global health experts discuss how to address the increasingly urgent issue of multi-morbidity and share different examples of integrated TB and diabetes care – from clinical to country and global perspectives.